Stem Cells Give Hope for Knee Pain: What the Experts Say

A growing number of people suffer from knee osteoarthritis, a condition that can make walking and everyday activities hard. Even when doctors follow the usual care plans—like pain medicine, physical therapy, and lifestyle changes—many patients still see their knees get worse. Scientists have turned to a new approach: using stem cells taken from bone marrow of healthy donors. These allogeneic mesenchymal stem cells are believed to calm inflammation, help the immune system stay balanced, and protect cartilage from damage. To understand how useful this treatment really is, a group of specialists gathered to share their views on everything from how doctors diagnose the disease to how safe and effective the therapy is in real life. They highlighted that patients with moderate knee damage, classified as grade 2 or 3 on a common scale, are the ones most likely to benefit. The experts agreed that while current treatments mainly ease pain, they do not stop the joint from deteriorating.

Safety is a top concern. The panel discussed that stem cell injections have shown good tolerance in many studies, but long‑term data are still limited. They also pointed out that using cells from donors eliminates the risk of rejection, a problem seen with other transplant types. In practice, the experts suggested that doctors should carefully select patients who have not responded to standard care and who show clear signs of joint wear. They also emphasized the need for proper monitoring after treatment, including imaging and functional tests, to track progress. The discussion concluded that while early results are promising, more large‑scale trials are needed to confirm how well allogeneic bone marrow stem cells can slow or reverse knee osteoarthritis. Researchers and clinicians must keep working together to turn this hopeful idea into a reliable treatment option.

Actions